Trending News

Blog Post

News

Pfizer, BioNTech request expanded emergency use of Covid-19 vaccine for ages 12-15 


Pfizer and its German companion BioNTech stated on Friday they’ve requested the U.S. Meals and Drug Administration to broaden the emergency use of their Covid-19 vaccine in adolescents aged 12 to fifteen.

In March, the drugmakers stated the vaccine was discovered to be secure, efficient and produced strong antibody responses in 12- to 15-year olds in a medical trial.

Whether or not Covid-19 vaccines work and are secure to make use of on kids is without doubt one of the huge questions drugmakers are attempting to reply. Inoculating kids and younger individuals is taken into account a essential step towards reaching “herd immunity” and taming the pandemic, based on consultants.

The businesses plan to request comparable rulings by different regulatory authorities globally within the coming days.

The Pfizer/BioNTech two-shot vaccine is already licensed to be used in individuals as younger as 16. 



Supply hyperlink

Related posts

Leave a Reply

Required fields are marked *